Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial

By  

Clinical Cardiology, Vol. 41, Iss. 1, 2018-01 ,pp. : 39-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

By Gibson C.   Zorkun Cafer   Molhoek Peter   Żmudka Krzysztof   Greenberg Mark   Mueller Hiltrud   Wesdorp Jan   Louwerenburg Hans   Niederman Alan   Westenburg Jaap   Bikkina Mahesh   Batty John   Winter Jobst   Murphy Sabina   McCabe Carolyn  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 1, 2006-08 ,pp. : 13-21

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) Trial

By Roy D.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 208-210

Springer Publishing Company

Access to resources Recommend Favorite

Detection of Atrial Fibrillation by Permanent Pacemakers: Observations from the STOP AF Trial

By Plummer C.J.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 333-340

Springer Publishing Company

Access to resources Recommend Favorite